Brief: Edwards Lifesciences Completes Sale Of Critical Care
03/09/2024 22:28
Sept 3 (Reuters) - Edwards Lifesciences Corp EW.N :
* EDWARDS LIFESCIENCES COMPLETES SALE OF CRITICAL CARE
* EDWARDS LIFESCIENCES CORP - COMPANY ANNOUNCES $1 BILLION
SHARE
REPURCHASE
* EDWARDS LIFESCIENCES CORP - BOARD AUTHORIZES ADDITIONAL
$1.5
BILLION FOR SHARE REPURCHASE
Source text for Eikon: ID:nBwcftHc6a
Further company coverage: EW.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edwards Lifesciences
See all newsFDA flags Edwards heart-valve delivery system issue after death, injury (updated)
FDA flags Edwards heart-valve delivery system issue after death, injury
Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
Brief: Edwards Lifesciences Corporation - Maintains Confidence In Financial Guidance For 2026
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals